Living with Interstitial Lung Disease Discover Stem Cell Therapy to Enhance the Quality of Life

The ability to breathe easily both in and out is something that we often consider to be a given. The natural rhythm we're born with is a quiet symphony, taking us through the whirlwind of our lives. Even when we refer to something as amazing as breathtaking, we are breathing into (and to exhale)!

However, for someone who has difficulty with this daily ability due to changes in the structure of the lung tissue, each breath could be difficult.

Interstitial Lung Disease (ILD) is a broad category of lung disorders that are characterized by scarring and inflammation in tissues of the lungs. Although the traditional treatments for ILD are focused on treating symptoms and reducing the rate of progression of the disease but they are not doing much to improve the quality of life. This is why stem cell therapy can provide the possibility of a bright future for patients. Let's explore the possibilities of the cutting-edge stem cell therapy for ILD which is offered at our centre in Bangalore.

Understanding Interstitial Lung Disease

ILD is a broad name for a range of lung disorders that are characterized by scarring and inflammation of the interstitium, which is the tissue that surrounds the air sacs (alveoli) within the lung. The scarring (fibrosis) results in the stiffening and thickening of lung tissue decreasing its capacity for expansion and contraction when breathing. ILD encompasses a variety of disorders, such as Idiopathic pulmonary Fibrosis (IPF) and connective tissue diseases that cause ILD. ILD is a group of disorders that share an underlying feature that is persistent destruction of the lung that can eventually lead to impaired breathing and symptoms of respiratory.

Signs and symptoms that are a sign of Interstitial Lung Disease

Dry cough

Breathing shortness

Fatigue

The tightness or discomfort of the chest.

Joint and muscle pain

Unexplained weight loss

Cyanosis (blue hue of lips and/or fingernails)

Abnormal growth (clubbing) in the toes and fingers (indicative the presence of oxygen deficiency)

The causes in Interstitial Lung Disease

Autoimmune disease

The adverse effects of certain medications

Radiation

Infections

Hypersensitivity pneumonitis

Family heritage

Exposure to toxic substances

Stem Cell Therapy for ILD

At Plexus, we make use of mesenchymal stem cell (MSCs) because of their ability to reduce inflammation, encourage the repair of tissues, and assist in the regrowth injured cells.

In addition, we can utilize stem cells derived from the umbilical cord to maximize the regenerative potential of stem cells and to treat the root cause of damage to lung tissue.

Below are the most important features of stem cells that are what make them the best option for treating ILD.

anti-inflammatory effects

MSCs possess potent anti-inflammatory properties. They can regulate the immune system and help reduce inflammation in the lung. This slows the process of progression of diseases to a significant extent.

Modulation of Fibrosis

ILD is generally defined by the over-deposition of collagen, as well as various other types that lead to the development of fibrosis. MSCs regulate fibrotic processes and assist in slowing down or reverse the scarring of lung tissue.

The stimulation of Repair Mechanisms

MSCs release factors that in stimulating local healing mechanisms, which include encouraging the development of new blood vessels as well as supporting the repair and repair of cells damaged. This is a major factor in lung function improvement.

Immunomodulation

An immune system that is not functioning properly is a common symptom of ILD. The properties of immunomodulation in MSCs aid in restoring a healthy immune system and stop any further damage to lung tissue.

Stem Cell Therapy for ILD in Bangalore

In the center of Bangalore, Plexus Neuro Center is a center of medical innovations, specifically stem cells therapy. With a clinical history of more than thirty years Plexus has become India's only stem cell research facility that has been certified ISO. Following our stem cell therapy for ILD Many patients have experienced significant improvements in their lives. This includes:

Breathing problems are less frequent.

Energy levels are increasing

Better overall health

We provide customized treatments that's tailored to your needs and symptoms. It is possible to prevent further degradation of lung function by choosing stem cell treatment in the treatment of Interstitial Lung Disease today.

FAQs

Can stem cells cure interstitial lung disease?

The use of stem cells for ILD enhances the health by reducing the intensity of symptoms, and slowing the progress of the disease and reducing inflammation in the lung, and dramatically improving the function of the lung.

What's the new approach to ILD?

The stem cell treatment is among the most recent and most advanced type therapy for ILD.

What is the most effective method of treating interstitial lung diseases?

The best method of treating the condition known as interstitial lung diseases (ILD) is dependent on the particular type and the underlying causes. At Plexus we suggest stem cell therapy to be at the top of a multidisciplinary approach that involves drugs, rehabilitation for the lungs, as well as oxygen therapy.

What are the initial signs of ILD?

The first indications of ILD include a persistent dry cough and shortness of breath after exercising, fatigue, or an unproven loss of weight. As the ILD progresses, symptoms can become worsened, leading to an increase in breathing problems and a decrease in fitness tolerance.

What can I do to tell when my ILD is worsening?

If you are experiencing a rise in difficulty breathing, decrease in your exercise tolerance as well as fatigue that is greater or a persistent cough It could be a sign of progress of ILD. Early detection and intervention are essential to improve breathing and health.

A highly regarded neurologist and stem cell specialist, Dr Na’eem Sadiq studied neurology and clinical neurophysiology in London before working with some of England’s and the Middle East’s most prestigious medical institutions. He completed his MBBS